TY - JOUR
T1 - Microbial Metabolites as Ligands to Xenobiotic Receptors
T2 - Chemical Mimicry as Potential Drugs of the Future
AU - Dvorak, Zdenek
AU - Li, Hao
AU - Mani, Sridhar
N1 - Publisher Copyright:
Copyright © 2023 by The American Society for Pharmacology and Experimental Therapeutics.
PY - 2023/2/1
Y1 - 2023/2/1
N2 - Xenobiotic receptors, such as the pregnane X receptor, regulate multiple host physiologic pathways including xenobiotic metabolism, certain aspects of cellular metabolism, and innate immunity. These ligand-dependent nuclear factors regulate gene expression via genomic recognition of specific promoters and transcriptional activation of the gene. Natural or endogenous ligands are not commonly associated with this class of receptors; however, since these receptors are expressed in a cell-type specific manner in the liver and intestines, there has been significant recent effort to characterize microbially derived metabolites as ligands for these receptors. In general, these metabolites are thought to be weak micromolar affinity ligands. This journal anniversary minireview focuses on recent efforts to derive potentially nontoxic microbial metabolite chemical mimics that could one day be developed as drugs combating xenobiotic receptor–modifying pathophysiology. The review will include our perspective on the field and recommend certain directions for future research.
AB - Xenobiotic receptors, such as the pregnane X receptor, regulate multiple host physiologic pathways including xenobiotic metabolism, certain aspects of cellular metabolism, and innate immunity. These ligand-dependent nuclear factors regulate gene expression via genomic recognition of specific promoters and transcriptional activation of the gene. Natural or endogenous ligands are not commonly associated with this class of receptors; however, since these receptors are expressed in a cell-type specific manner in the liver and intestines, there has been significant recent effort to characterize microbially derived metabolites as ligands for these receptors. In general, these metabolites are thought to be weak micromolar affinity ligands. This journal anniversary minireview focuses on recent efforts to derive potentially nontoxic microbial metabolite chemical mimics that could one day be developed as drugs combating xenobiotic receptor–modifying pathophysiology. The review will include our perspective on the field and recommend certain directions for future research.
UR - http://www.scopus.com/inward/record.url?scp=85147046668&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85147046668&partnerID=8YFLogxK
U2 - 10.1124/dmd.122.000860
DO - 10.1124/dmd.122.000860
M3 - Review article
C2 - 36184080
AN - SCOPUS:85147046668
SN - 0090-9556
VL - 51
SP - 219
EP - 227
JO - Drug Metabolism and Disposition
JF - Drug Metabolism and Disposition
IS - 2
ER -